J. Ferlay, E. Steliarova-foucher, J. Lortet-tieulent, S. Rosso, J. W. Coebergh et al., Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012, Eur J Cancer, vol.49, pp.1374-403, 2013.

I. Rosa, J. Denis, R. P. Lesgourgues, B. Dobrin, A. S. Becker et al., A French multicentric longitudinal descriptive study of hepatocellular carcinoma management (the CHANGH cohort): preliminary results, J Hepatol, vol.52, pp.231-233, 2010.

E. , clinical practice guidelines: management of hepatocellular carcinoma, J Hepatol, vol.56, pp.908-951, 2012.

J. Bruix and M. Sherman, Management of hepatocellular carcinoma, Hepatology, vol.42, pp.1208-1244, 2005.

J. Bruix and M. Sherman, Management of hepatocellular carcinoma: an update, Hepatology, vol.53, pp.1020-1022, 2011.

, EASL clinical practical guidelines : management of alcoholic liver disease, J Hepatol, vol.57, pp.399-420, 2012.

D. Kansagara, J. Papak, A. S. Pasha, M. O'neil, M. Freeman et al., Screening for hepatocellular carcinoma in chronic liver disease: a systematic review, Ann Intern Med, vol.161, pp.261-270, 2014.

P. Jepsen, P. Ott, P. K. Andersen, H. T. Sorensen, and H. Vilstrup, Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis: a Danish nationwide cohort study, Ann Intern Med, vol.156, issue.12, pp.841-848, 2012.

J. West, T. R. Card, G. P. Aithal, and K. M. Fleming, Risk of hepatocellular carcinoma among individuals with different aetiologies of cirrhosis: a population-based cohort study

, Aliment Pharmacol Ther, vol.45, issue.7, pp.983-990, 2017.

A. Mancebo, M. L. Gonzalez-dieguez, V. Cadahia, M. Varela, R. Perez et al., Annual incidence of hepatocellular carcinoma among patients with alcoholic cirrhosis and identification of risk groups, Clin Gastroenterol Hepatol, vol.11, pp.95-101, 2013.

K. G. Alberti, P. Zimmet, and J. Shaw, The metabolic syndrome-a new worldwide definition, Lancet, vol.366, pp.1059-62, 2005.

Y. Liu, Sensitivity analyses for informative censoring in survival data: A trial example

, J Biopharm Stat, vol.27, issue.4, pp.595-610, 2017.

N. Fujiwara, S. L. Friedman, N. Goossens, and Y. Hoshida, Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine, J Hepatol, issue.17, pp.168-8278, 2017.

J. Y. Hsu, J. A. Roy, D. Xie, W. Yang, H. Shou et al., Statistical Methods for Cohort Studies of CKD: Survival Analysis in the Setting of Competing Risks, Clin J Am Soc Nephrol, vol.12, issue.7, pp.1181-1190, 2017.

I. R. White, P. Royston, and A. M. Wood, Multiple imputation using chained equations: Issues and guidance for practice, Stat Med, vol.30, pp.377-99, 2011.

G. S. Collins, J. B. Reitsma, D. G. Altman, and K. Moons, Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement, BMJ, vol.162, pp.55-64, 2015.

J. C. Trinchet, V. Bourcier, C. Chaffaut, A. Ahmed, M. Allam et al., Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort), Hepatology, vol.62, pp.737-50, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01201948

P. Nahon, V. Bourcier, R. Layese, E. Audureau, C. Cagnot et al., Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications, Gastroenterology, vol.152, pp.142-156, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01447065

A. J. Van-der-meer, J. J. Feld, H. Hofer, P. L. Almasio, V. Calvaruso et al., Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication, J Hepatol, vol.66, pp.485-93, 2017.

J. C. Trinchet, C. Chaffaut, V. Bourcier, F. Degos, J. Henrion et al.,

, Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3-and 6-month periodicities, Hepatology, vol.54, pp.1987-97, 2011.

C. Costentin, N. Goutte, and P. Sogni, Patients with Alcohol Compared to Hcv-Related Hepatocellular Carcinoma (HCC) Have a Reduced Survival, Results of a Nationwide Study, Hepatology, vol.62, p.399, 2015.

P. Jepsen, T. L. Lash, and H. Vilstrup, The clinical course of alcoholic cirrhosis: development of comorbid diseases. A Danish nationwide cohort study, Liver Int, vol.36, pp.1696-1703, 2016.

A. G. Singal, A. Pillai, and J. Tiro, Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis, PLoS Med, vol.11, p.1001624, 2014.

, Bio-bank (serum, plasma, DNA) at